Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Characterization of hematopoietic stem cells from the canine yolk sac

Full text
Author(s):
de Sousa, Barbara Rossi [1] ; de Oliveira, Vanessa Cristina [1] ; Pinheiro, Alessandra Oliveira [1] ; Ambrosio, Carlos Eduardo [1]
Total Authors: 4
Affiliation:
[1] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Med Vet, Pirassununga, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: ANIMAL REPRODUCTION; v. 18, n. 2 2021.
Web of Science Citations: 0
Abstract

The characterization of hematopoietic stem cells (HSC) from the canine yolk sac (cYS) can contribute to future gene therapies because it is possible to obtain information about the beginning of the development of the circulatory system through the characterization. The cYS is a likely source of HSC, which is a source of blood cell development in mammals. Studies in this field have been conducted for decades; however, interest in cellular therapy is currently at its peak with greater visibility, and these cells are a promising therapeutic tool for the treatment of diseases related to animals and humans. The aim of this study was to isolate and characterize HSC from the cYS embryos at 30 to 45 days of gestational age. Our results showed that the cYS was macroscopically located in the ventral region with a central portion and extremities. The cells in culture presented a circular morphology and cell clusters. The average cell viability was 22.55% dead cells out of 6.5 x 10(4) total cells. The cells were also able to form colonies on methylcellulose. Flow cytometry analysis revealed the expression of CD34, CD117, and CD45. Our results suggest that the cYS can be used as a source of hematopoietic cells, and this study is very important to understand the mechanism and development of the hematopoietic system in dogs. (AU)

FAPESP's process: 17/21266-0 - Amniotic Progenitor cells and therapeutics potention
Grantee:Carlos Eduardo Ambrósio
Support Opportunities: Regular Research Grants